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Covalent attachment of ubiquitin to substrates is crucial to protein degradation, transcription
regulation and cell signalling. Highly speciﬁc interactions between ubiquitin-conjugating enzymes
(E2) and ubiquitin protein E3 ligases fulﬁl essential roles in this process. We performed a global
yeast-two hybrid screen to study the speciﬁcity of interactions between catalytic domains of the 35
human E2s with 250 RING-type E3s. Our analysis showed over 300 high-quality interactions,
uncovering a large fraction of new E2–E3 pairs. Both within the E2 and the E3 cohorts, several
members were identiﬁed that are more versatile in their interaction behaviour than others. We also
foundthatthephysicalinteractionsofourscreencomparewellwithreportedfunctionalE2–E3pairs
in in vitro ubiquitination experiments. For validation we conﬁrmed the interaction of several
versatile E2s with E3s in in vitro protein interaction assays and we used mutagenesis to alter the E3
interactions of the E2 speciﬁc for K63 linkages, UBE2N(Ubc13), towards the K48-speciﬁc
UBE2D2(UbcH5B). Ourdata provide a detailed, genome-wide overviewof binary E2–E3 interactions
of the human ubiquitination system.
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Introduction
Modiﬁcation of proteins with ubiquitin (ubiquitination)
regulates the degradation of proteins by the 26S proteasome,
but also serves a wide variety of other cellular processes,
ranging from endocytosis to cell death (Pickart, 2001).
Complex and tightly regulated protein–protein interactions
(PPIs) of three key enzymes, ubiquitin-activating enzymes
(E1s), ubiquitin-conjugating enzymes (E2s) and ubiquitin
protein ligases (E3s), allow that ubiquitin becomes activated
and covalently linked to substrates (Pickart, 2001; Dye and
Schulman, 2007). These E1, E2 and E3 enzymes are operating
in a hierarchical system. In the human genome, two E1s have
been identiﬁed, responsible for the activation and transfer of
ubiquitin (Ub) to the E2s (Haas et al, 1982; Jin et al, 2007). In
contrast, over 30 E2s have been identiﬁed, and these have in
common a highly conserved 150–200 amino-acid catalytic
domain (Pickart, 2001). This UBC domain consists of several
a-helices, b-sheets and variable loop regions, which are
surrounding an active-site cysteine residue (Burroughs et al,
2008). Flanking this conserved region, additional N- and/or
C-terminal extensions have been found that are involved in
substrate selection, dimerization and additional processes
(Silveret al,1992; Haldemanet al,1997; Summerset al,2008).
E2s are transferring the activated ubiquitin to E3s, character-
ized by the presence of either an HECT (Homologous to E6-AP
Carboxy-Terminus) (Hatakeyama and Nakayama, 2003;
Bernassola et al, 2008), U-box (Hatakeyama and Nakayama,
2003) or Really Interesting New Genes (RING) domain (Ardley
and Robinson, 2005). The RING-ﬁnger domain is a highly
conserved pattern of cysteine and/or histidine residues,
chelating two atoms of zinc in a highly typical cross-brace
structure. RING-type E3s can bind E2s through their RING-
ﬁnger, but in contrast with HECT-type E3s, they catalyse the
direct transfer of ubiquitin from the E2 to a substrate (Ardley
and Robinson, 2005). Interactions between E2s and E3s are
& 2009 EMBO and Macmillan Publishers Limited Molecular Systems Biology 2009 1
Molecular Systems Biology 5; Article number 295; doi:10.1038/msb.2009.55
Citation: Molecular Systems Biology 5:295
& 2009 EMBO and Macmillan Publishers Limited All rights reserved 1744-4292/09
www.molecularsystemsbiology.comthought to be important because the interacting E2 dictates the
type of inter-ubiquitin linkages and thereby determines the
fate of the substrate. For example, ubiquitin chains linked
through lysine 48 (i.e. by UBE2D2(UbcH5B)) are targeted by
the 26S proteasome for degradation (Finley et al, 1994),
whereas UBE2N(Ubc13)-mediated K63-linked ubiquitin
chains are involved in signalling (Deng et al, 2000).
A limited number of clues, obtained by experimental
structures, showed that E3 interactions are occurring in the
UBC-fold(Huangetal,1999;Schulmanetal,2000;Zhengetal,
2000; Christensen et al, 2007; Poyurovsky et al, 2007; Xu et al,
2008). Large-scale, genome-wide PPI studies can make an
important contribution in the understanding of the speciﬁcity
of E2–E3 interactions. Aiming to map E2–E3 interactions on a
genome-wide scale and to study the underlying selectivity of
these binary complexes, we have used a yeast two-hybrid
(Y2H) screen, including 35 E2 UBC-folds and 250 E3
RING-ﬁnger domains. Our analysis showed more than 300
binary E2–E3 interactions, of which a large proportion was
not known earlier. As expected we found that multiple E2 and
E3 enzymes could interact with multiple E3s and E2s,
respectively. Some of the E2s and E3s seemed to be more
versatile than others and showed more interactions than
the average number one would expect, thereby conferring
to the concept of hubs in protein interaction networks.
Comparing the physical E2–E3 interactions with reported
E2–E3 pairs assayed in in vitro ubiquitination reactions
showedahighlevelofagreement.Oneofthehighlyinteracting
E2s,UBE2U, an earlier unknown C-terminal extended, class III
E2, showed the highest number of interactions. We validated
the interaction between UBE2U and the E3 ligase MDM2
and also several interactions between hub E2s and E3s
by independent GST-pull-down analysis, indicating a high
level of conﬁdence of the found E2–E3 interactions. On the
basis of the interaction network we generated mutants
of UBE2N(Ubc13) to mimic the E3 interaction pattern of
UBE2D2(UbcH5B). This resulted in new E3 interactions,
which allows manipulation of ubiquitination pathways in
living cells. The experimental interactions found in this study
provide a global, high-resolution framework for structural and
functional studies towards the organization and selectivity
between E2 and E3 enzymes.
Results
Central in the process of ubiquitination are the interactions
between ubiquitin-conjugating enzymes (E2) and ubiquitin
protein ligases (E3). To gain more insight into the selectivity of
binary E2–E3 complexes, we devised a systematic and
genome-wide Y2H screen. Earlier work by others and by our
group showed that these interactions are highly selective, and
that Y2H assays are powerful tools to study these speciﬁcities
(Winkler et al, 2004; Christensen et al, 2007). This screen was
performed to generate a framework of binary E2–E3 interac-
tions. Interactions between the individual UBC-folds and the
RING-ﬁnger domains are the major contributors to E2–E3
interactions (Lorick et al, 1999). Therefore, in a ﬁrst approach
we limited ourselves to screen for the interactions of human
UBC-folds with RING-ﬁnger domains.
Annotating the human ubiquitin-conjugating
enzymes
It has been estimated earlier that within the human genome,
30–40 E2s are present (Pickart, 2001). To precisely annotate
the complete human E2 superfamily, we searched human
cDNA databases for candidates. Our search showed 52 E2
family members that contain the UBC-fold (Supplementary
Table I). Of these 52 E2s, we identiﬁed 16 pseudogenes for
which no expressed protein-coding mRNAs could be found.
We also identiﬁed an additional E2-like enzyme, UBE2N-like,
lacking the central ubiquitin-accepting cysteine. Among the
remaining 35 enzymes, three E2s were annotated as putative
E2s and no ubiquitin(-like)-conjugating activity has been
reported for these (UBE2D4, UBE2W and UBE2U) so far.
Recently, ithas been shown that UBE2F has theability to act as
a second NEDD8 E2 and prefers interaction with the Rbx2
RING protein, adding divergence to the NEDDylation system
(Huang et al, 2009). So at this moment, 31 E2 enzymes are
described to be involved in the process of ubiquitin or
ubiquitin-like protein conjugation. Among these E2s, there
are well-known examples with biochemically active roles
in protein ubiquitination, such as UBE2D2(UbcH5B) and
UBE2L3(UbcH7) (Shimura et al, 2000; Ozkan et al, 2005).
Apart from the wild-type (WT) E2s, we also included the
UbcH5B(K63E)mutant,whichhasbeenshownearliertofailto
interact with the WT CNOT4 RING-ﬁnger, but showed an
altered-speciﬁcity interaction with the D48K/E49K double
mutated CNOT4 (Winkler et al, 2004). Using multiple
sequence alignments, we determined the boundaries of the
UBC-fold. These 36 UBC-folds were fused to the C-terminus
of LexA, DNA sequence veriﬁed, transformed in MATa
cells and arranged in a standardized array (BD–E2 array)
(Figure 1B and D).
Selection of human RING-type E3s
Recent genome-wide annotations of human E3 ubiquitin
protein ligases have indicated that there are 300 RING-type
and 9 U-box-type E3s present within the human genome (Li
et al, 2008). To select a representative collection of these
domains,genome-widedatabasesearcheswereinitiated.First,
we performed a SMARTsearch using the curator-deﬁned RING
signature (SM00184) and this yielded 520 hits of which 314 of
them were unique. Second, we performed a ScanProSite using
ProSite pattern PS50089 against the human sequences
deposited in SwissProtþTrembl (UniProt) generating a multi-
ple sequence alignment of 627 hits in 611 UniProt sequences.
Third,we performed a PSI-BLASTsearchof the human CNOT4
sequence against SwissProt, sequences with ‘RING’ in their
name were retained during the process, with ‘ubiquitin ligase’
in some steps retained and without these names removed
in some steps. Finally, all sequences with an expectation of
1.1 and lower were selected and this yielded 217 hits. Finally,
we constructed a list of 308 Ensembl entries containing
InterPro domain IPR001841. Next, these entries were cleared
of redundancies and converted to UniProt codes and full-
length protein sequences, which were retrieved from
SwissProt. To locate the RING signature, a RING-ﬁnger
matching tool was written and from the 295 sequences, we
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aligned in a multiple sequence alignment using Clustal W. The
resulting alignment was carefully corrected by hand, espe-
cially with respect to zinc-binding regions. Regions that could
not be aligned with any degree of reliability, for example
sequences containing more than four C/HXXC/H, were
removed from the alignment. In total, 313 RINGs were
successfully aligned, 161 of them being classiﬁed as proper
RING (matching the CXXC[X](10–51)C[X](1–3)H[X](2–5)
CXXC[X](4–60)CXXC signature), 16 as PHD (matching CXXC[X]
(8–31)C[X](2–4)C[X](2–5)HXXC[X](12–60)CXXC) and 11 of
them as FYVE (matching CXXC[X](12–40)CXXXXCXXC[X]
(13–80)CXXC). We identiﬁed 111 E3s being uncommon, as
they match the following signature [C/H]XX[C/H][X](0–86)
[C/H][X](0–5)[C/H][X](0–29)[C/H]XX[C/H][X](0–86)[C/H/D],
wherein X could be any amino acid, except a C or an H. We also
found 14 E3s being incomplete, belonging to none of the
signatures. Together, 177 sequences are expected to act like E3
ligases, for 25 this is not expected, because they lack a
complete RING signature and for the remaining 111 this
remains unclear. Of these RING sequences we obtained clones
for 250 human RING-ﬁnger/U-box E3 ligases (80.9% coverage
of total (250/309)), based on cDNA availability. The RING-
ﬁnger/U-box domains were subcloned as C-terminal fusions
with the B42 activation domain (AD), under control of a
galactose-inducible promoter. All B42–E3 constructs were
veriﬁed by DNA sequencing and arrayed as a library of 250
B42–RING fusions in MATa yeast cells (AD–E3 array) (Supple-
mentary Table II). Correct expression of the B42 fusions was
evaluated using immunoblotting (data not shown).
Genome-wide E2–E3 yeast-two hybrid screen
Systematic mating crosses between the BD–RING and AD–E2
arrays allowed scoring for putative interactions between the
arrays of E2 domain and E3 domain. Each of the 36 LexA–E2
fusions was arrayed in three independent yeast transformants.
These three spots were placed in a small square together with
LexA-only, measuring E2–E3 interactions in triplicate parallel
to the empty vector control (Figure 1A). EGY48a cells
transformed with B42–RING fusions were spotted on top of
the BD–E2 arrays. After mating, diploids were selected and
1. 2.
3. 4.
Spot 1-3: Biological LexA–E2 triplicates
Spot 4: Empty LexA–vector
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Figure 1 Outline array based, mating yeast two-hybrid matrix screen. (A) Organization of LexA–E2 fusions as three independent bacterial triplicate clones and an
empty LexA vector. (B) LexA–E2 protein expression levels. Total protein lysates of yeast cells transformed with LexA–E2 fusions were resolved on SDS–PAGE,
transferred to membranes and probed with either LexA antibody or yeast tubulin (TUB1). (C) Overview of experimental yeast two-hybrid screening procedure. EGY48a
cells were transformed with 36 LexA–E2 fusions and EGY48a cells were transformed with 250 B42–RING-fusions. Screening for pair-wise E2–E3 interactions was
carried out by standardized array-based mating between EGY48a and EGY48a cells on YPD for 24h at 301C, followed by diploid selection on SC HWU
  for 48h at
301C.InteractionswerevisualizedbytransferringdiploidsonSCHWU
 X-Gal(colorimetricselection)oronSCHWUL
 (auxotrophicselection)underbothB42-inducing
(galactose as main carbon source) and repressive (glucose) conditions. Digital images of the interactions were taken at 3, 24-h interval time points.( D) Overview of
standardized LexA–E2 array. Each spot represents EGY48a cells transformed with the indicated LexA–E2 fusion construct. Spots with a red square contained LexA–
UBE2D2 and LexA–UBE2D2 K63E constructs and were mated throughout the entire procedure with EGY48a cells transformed with B42–CNOT4 N63 as positive and
negative interaction controls, respectively. Spots with a green square were transformed with LexA–Caf40 and LexA–CNOT2-15 and served as auto-activating controls.
Blue squared spots represent either EGY48a cells transformed with LexA-empty vector and an untransformed EGY48a strain, as mating/growing controls.
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auxotrophic (LEU2-set) selection. A semi-automated pipeline
of digitalized plate photographs followed by spot size/colour
intensity quantiﬁcation on three time points, allowed us to
quantify interactions in an unbiased and sensitive manner
(Figure 1C).
Selection of interactors
Close to 10000 interactions within the 36 250 E2–E3 matrix
were assessed independently on LacZ and LEU2 reporter read-
outs. It has been shown earlier that, in general, interactions
that activate both reporters are of higher conﬁdence and more
reproducible than interactions that activate only one reporter
(Golemis et al, 2001). Therefore, our deﬁnition of an E2–E3
interaction is a galactose-dependent increase in both reporter
activities. To select the shared interactions, we determined
percentile values for both the LacZ- and the LEU2-set. As any
selection strategy has the potential risk of discarding true
positive and including false-positive interactions, selection of
the most suitable percentile cut-off was based on all E3
interactions foragivenE2.Giventhevariabilityofspotsizesin
the LEU2 dataset, we concluded that interaction values from
50–200 pixels are the consequence of either noise (false
positives), absence of LEU2-reporter activation (true-negative
interactions) or weak-activating interactions. To avoid the risk
of discarding true interactions, all interactors in the LEU2-set
above the 75th percentile were selected (2238 signals). From
the LacZ-set with a total of 577 blue signals we selected all
interactors above the 50th percentile (562 interactors, 94.4%
of total). Combining these two sets resulted in 346 high-
conﬁdence interactors (15.5% of LEU2-set and 61.6% of the
LacZ-set), which we named the LL-set (Figure 2A; Supple-
mentary Table III). An overview of all the identiﬁed E2–E3
interactionsscoredbybothLacZstainingandLEU2selectionis
given in Supplementary Tables IVand V, respectively.
Human E2–E3 domain–domain interactions
Inspecting the connectivity, that is the numbers of E3
interactions for each E2 in the LL-set, we identiﬁed 20 E2s
that were connected to at least one E3 and 16 E2s that did not
show any E3 interaction (Figure 2B). Screening the E3
domains, we found 104 E3s that were connected to at least
one E2 and 147 E3s that did not show any E2 interactions. An
overview of the E3 connectivity is shown in Figure 2C.
The E2s showing the highest number of interactions were
UBE2U (52 interactors), followed by UBE2D2 (35), UBE2D3
and UBE2D4 (33), UBE2N (29), UBE2D1 (28) and the K63E
mutant of UBE2D2 (27). Next, UBE2W, UBE2E1, UBE2E3,
UBE2G2, UBE2Z, UBE2L6 and UBE2J2 showed 8–22 E2
interactions. Smaller number of interactions was found for
UBE2H (three), UBE2Q1 (two), UBE2C (one), UBE2E2 (one)
and UBE2Q2 (one) (Figure 2A). To investigate the possibility
that differences in E3 interaction patterns were because of
differences in LexA protein expression, immunoblot analysis
was performed. Figure 1B shows that the majority of LexA–E2
fusions are expressed at similar levels and that only some E2s
are expressed at low levels (UBE2Q2 and UBE2I(Ubc9)).
Please note that we ﬁnd one E3 interaction (PCGF2) for
UBE2Q2 and, as expected, no interactions for the SUMO-
speciﬁc UBE2I(Ubc9). Expression of UBE2F and UBE2K could
not be detected, which correlates with the absence of E3
interactions.Of the other 13non-interactors,ﬁveE2s (UBE2M,
BIRC6, UBE2O, UBE2V1 and UBE2V2) have not been linked to
ubiquitin conjugation, but in some cases to conjugation of
ubiquitin-like proteins. It is important to note that we do not
observe an over-representation of a particular class of E2s,
indicating that N- or C-terminal extensions to the UBC-fold are
not confounding the results (data not shown). We also
analysed a potential effect of the position of the RING within
the full-length E3 on interaction potential (Supplementary
Table II). This indicated that N-terminal RING domains score
slightly lower in E2 interactions as compared C-terminal
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Figure 2 Topological characterization of the E2–E3 network. (A) Venn
diagram showing the shared E2–E3 interactions in the 75th percentile selected
LEU2-set and the 50th percentile selected LacZ-set and the overlap between
them. (B) Distribution of the E3 connectivity for each individual E2. Depicted are
the numbers of E3 interactions observed in the shared LacZ- and LEU2-set
among all interactions of a single E2. (C) Distribution of the E2 connectivity for
each individual E3, idem as panel B.
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indicate that the interactions are distributed broadly over the
different classes and types of E2 and E3 enzymes.
Topological characteristics of the E2–E3
interaction network
The E2–E3 interaction map can be regarded as a network, in
which individual E2s and E3s are considered as nodes
(Figure 3), which are connected to each other through
interactions. In total, we found 346 interactions between 20
E2 and 104 E3 domains,with an average of 2.8 interactions per
domain (Figure 3). The connectivity of both the E2s and E3s
interactions indicate the presence of several high and lesser
connected E2 and E3 domains. Our analysis showed that
UBE2U, the UbcH5 family of highly homologous E2s (UBE2D1-4),
UBE2N and UBE2E1 and UBE2E3 showed a high number of E3
interactions (Figures 2B and 3). UBE2U is an E2 enzyme,
which carries a C-terminal extension attached to its UBC-fold
and thus belongs to the class III group of E2 enzymes. At
present no interaction data for UBE2U or an ubiquitin(-like)
conjugation activity have been described in the literature,
which may be related it its restricted expression pattern in the
urogenital tract (based on mRNA expression proﬁle, data not
shown). Members of the UbcH5 family are highly conserved
E2 enzymes and homologous to yeast UBC4/5. These E2s are
involved in the degradation of misfolded and short-lived
proteins and have been shown to be active in ubiquitination
(Seufert and Jentsch, 1990). UBE2N(Ubc13) forms hetero-
Figure 3 E2–E3 network. A network graph of binary E2–E3 domain interactions involving 124 E2 and E3 domains linked through 346 interactions. Nodes (domains)
are shown as circles and interactions between them as black lines. E2 domains are shown as red circles and E3 domains as blue circles. The size of each node is linear
related to the number of links of that node. Red square depicts E2 hub proteins, blue square hub E3s. Figure was generated using Cytoscape v.2.6.1.
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ubiquitin chain assembly (Deng et al, 2000). UBE2G2 is the
human homolog of the yeast UBC7 and resides in the
endoplasmatic reticulum (ER). UBE2G2 has been reported to
interact with the E3 ligase gp78 (AMFR) and this E2–E3 pair
has a role in ER-associated degradation (ERAD) (Chen et al,
2006). Another characteristic of hub proteins is that they
connect to proteins with only a few interactions (Maslov and
Sneppen, 2002). This is clearly illustratedby the E3 interaction
patterns of UBE2U and UBE2G2. On the other hand, UBE2D1-4
interact with well-connected E3s.
The hierarchical nature of the ubiquitin-conjugation ma-
chinery allows a ﬂux of activated ubiquitin from the activation
bytheE1throughE3stodownstreamtargets.TheroleofE2sin
this process is to maintain the robustness of the system as a
whole and to connect the activation of ubiquitin with its
conjugation to substrates. Therefore, deletion of the E2s with
high numbers of E3 interactions could have severe conse-
quences for the complete ubiquitination network. To investi-
gatethis,wesystematicallyremoved(hub)E2sfromtheE2–E3
networkand quantiﬁed thenumberof E3s that become uncon-
nected (Supplementary Figure 2). By removing UBE2U, 32 E3s
become unconnected, whereas 20 remain connected to another
E2. In contrast, removing UBE2D2 has only very mild effects,
because many E3s interact with the homologous UBE2D1, -D3
and -D4 and to a lesser extent with UBE2E1 and UBE2E3.
Interestingly, removal of UBE2G2 from the network leaves seven
E3s unbound. As this E2 is localized in the ER and is involved in
ERAD, it fulﬁls a central role in the network. Finally, deletion of
UBE2Z from the network disconnects two RING domains from
the recently identiﬁed second E1 for ubiquitin, Uba6.
Apart from the WT E2s tested in this screen, the
UBE2D2(UbcH5B) loop 1 mutant (K63E) was also included.
As shown earlier, contrary to WT UBE2D2, the K63E mutant is
not able to bind to WTCNOT4 (Winkler et al, 2004). However,
when mutating the UBE2D2-interacting residues in the CNOT4
RING-ﬁnger such that they swap their charges (D48K/E49K),
complete rescue of interaction could be achieved. Interest-
ingly, UBE2D2 K63E does not showa dramatic change in its E3
interaction pattern compared with WT UBE2D2 and several
E3s are interacting with both WT and the mutant UBE2D2.
Strikingly, UBE2D2 K63E gained interactions with LOC51136,
NFX1 and RNF8 as compared with the WTenzyme. Inclusion
of the D48K/E49K mutant of the CNOT4 RING-ﬁnger shows
loss of binding with the UbcH5 family, UBE2E1, UBE2E3 and
UBE2W and, as expected it displays speciﬁc binding with
UBE2D2 K63E. The mutant CNOT4 also showed a stronger
interaction with UBE2N(Ubc13) as compared with the WT E3
(Figure 4).
The presence of highly connected E2s and E3s provides the
network with robustness and resistance against small pertur-
bations. This implies the presence of selective structural
features involved in E2–E3 interaction speciﬁcity. To study the
underlying molecular determinants, E2s were selected that
exhibit more than one E3 interaction. First, the degree of
overlap in E3 interaction between these E2s was quantiﬁed as
the ‘hub overlap index’ (Supplementary Figure 3). These
numbers indicate the extent by which a certain E3 is used
for E2 binding. The hub overlap index indicates that the
homologous E2s, like UBE2D2, -D3, -D4 and to a lesser extent
UBE2D1, cluster together in E3 interaction pattern, indicating
that enzyme function is directly coupled to structural simil-
arities. The same is true for the homologous UBE2E1 and
UBE2E3 proteins, which share interactions with many E3s.
Surprisingly, the highly similar UBE2E2 displayed an E3
interaction pattern distinct from the proﬁles of UBE2E1 and
UBE2E3. The E2s UBE2N and UBE2W are highly connected,
but they exhibit lower amounts of overlap. Unexpectedly, the
highly connected UBE2U does not cluster together with the
other highly interacting E2s, but it interacts with many E3s,
suggesting a general role in ubiquitination in the urogenital tract.
To compare the hub overlap index with structural simila-
rities between E2s, we calculated the percentages of sequence
identity either for the complete UBC-fold or only for the
predicted E3-interacting interface (Supplementary Figure 4).
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roughly equals the pattern of the hub overlap index. For most
pairs, the sequence conservation clearly relates to the hub
overlap,asindicatedforthesub-clustersUBE2D1–D4,UBE2E1
and -E3 and UBE2N and UBE2W. This underscores a structural
basis among these E2 enzymes for E2 enzymes. In contrast,
UBE2E2 is highly similar to UBE2E1 and UBE2E3, but it
displays little interaction overlap. UBE2T is interesting in this
respect as it is equally similar to UBE2E1, UBE2E2 and
UBE2E3, but the UBE2T interaction pattern only overlaps with
that of UBE2E2. The similarity in the E3 interaction surfaces of
UBE2L6 and the UBE2D family is limited, but their E3
interaction proﬁles display a signiﬁcant degree of overlap.
Finally, the screen identiﬁed 11 E3 interactions for the
UBE2Z(Use1) E2 enzyme. Recently, it has been shown that this
E2 enzyme can become ubiquitin loaded by the newly identiﬁed
E1 enzyme, Uba6, in a manner discriminating against other E2
enzymes (Jin et al, 2007). The observed UBE2Z interactions
could provide a link between Uba6 and RING E3 ligases.
Among the screened E3 domains, RNF150, ZNRF4, CADPS2
and MUL1 showed the highest number of E2 interactions
(Figure 3). For RNF150, no E3 ligase activity has been
described, but the protein belongs to the human Goliath
family (Anandasabapathy et al, 2003). Strikingly, two other
Goliath family member E3s, RNF130 and RNF167 were also
found to act as hub proteins, with only 52% sequence identity
between the RING-ﬁngers. The RNF130 protein (hGoliath)
contains a protease-associated domain, a transmembrane
domain and a RING-ﬁnger domain and is the human homolog
of Drosophila’s g1, a zinc-ﬁnger protein, involved in embryo-
nic development (Guais et al, 2006). RNF130 displayed
auto-ubiquitination activity when interacting with UBE2-
D1(UbcH5A) and UBE2D3(UbcH5C), but not with a number
of other E2s (Guais et al, 2006). It would be interesting to
test whether RNF167 and RNF130 are also functional E3s.
A second example of multiple, highly homologous family
members acting as hub E3s come from the E3 ligases ZNRF4,
ZNRF1 and ZNRF2, having 51% sequence identity between
their RING-ﬁnger domains. These show 10, 6 and 5 E2
interactions, respectively. The ZNRF proteins are implicated
in spermatogenesis and the establishment and maintenance of
neuronal transmission and plasticity mediated by their E3
ligase activity (Fujii et al, 1999; Araki and Milbrandt, 2003).
CAPDS2 (calcium-dependent secretion activator 2) is involved
in the exocytosis of neurotransmitter vesicles and cerebellar
development (Sadakata et al, 2007). No E3 domain annota-
tions could be found for this protein, and information about
interacting E2s or ubiquitin-ligating activity is absent. MUL1
(MULAN) has been implicated recently in the establishment of
mitochondrial dynamics and mitochondria-to-nucleus signal-
ling, in a manner dependent on its RING-ﬁnger domain. MUL1
displayed auto-ubiquitination activity when tested with Ubc4,
the yeast homolog of the human UbcH5 family (Li et al, 2008).
Quality of the physical E2–E3 interaction network
Comparing the E2–E3 interactions obtained in this screen with
E2–E3 literature-curated interactions evaluates the quality of
the interactions in the E2–E3 network. Physical interactions
between E2 and E3 enzymes are required for efﬁcient
ubiquitination in vivo and in vitro and therefore for their
catalytic function. Besides this, comparing the novel E2–E3
pairsgenerated byourscreenwith annotated functional E2–E3
pairs provides insight into the functionality of the E2–E3 pairs.
We ﬁrst selected the top 10% interacting E3s and compared
their physical E2 interaction patterns with information
obtained by low-throughput E2–E3 experiments. As shown
in Figure 5, 25 hub E3s showed a total number of 209 E2
interactions covering 60% of the total number of E2–E3 two-
hybrid interactions. For the published literature we recovered
64 E2–E3 pairs for the 25 hub E3s; 35 of the 64 pairs were
positive for in vitro or in vivo ubiquitination activity and 29
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Figure 5 Quality of the E2–E3 network. Physical E2–E3 interactions in relation to literature-curated, functional E2–E3 pairs. Hub node E3s were selected and
interactions with E2s were scored when biochemically tested in in vitro ubiquitination assays as reported in literature.
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we conﬁrmed 33 in our screen, which we regard as true
positives (Figure 5). We found only two pairs that were
biochemically reported positive, but did not occur in the Y2H
screen (false negatives). The observed literature interactions
were mostly concerning the members of the UbcH5 family and
UBE2E1 and UBE2E3. To investigate the possibility that these
E2s are more versatile in ubiquitination reactions, we
compared reported E2–E3 combinations that were negative
inbiochemicalreactions.Ofthe29E2–E3interactionsreported
negative we recovered 24 in our dataset (true negatives). We
also found ﬁve pairs that were reportednegative in ubiquitina-
tion assays,but showed an interaction in the Y2H screen (false
positives). In conclusion, this indicates a speciﬁcity of 83%
(24/(5þ24)) and a sensitivity of 94% (33/(2þ33)) between
biochemically active E2–E3 pairs and pairs found interacting
in our screen. In the above analysis we focussed on the top
10% ofinteractors. Analysisof sensitivityandspeciﬁcityof the
complete data set is confounded by uncertainty of proper
folding and/or localization of the Y2H proteins (Supplemen-
tary Table VI), which are potential pitfalls of Y2H screening.
Therefore, we focussed on the E2 and E3s, which display at
least one interaction. This criterion retains 20 E2s and 104 E3s
from our screen. Literature inspection of this set showed 118
E2–E3 interactions of which 83 scored positive and 35
negative. Of the 83 positive interactions we recovered 48
interactions in our dataset. Of the 35 negative interactions 30
were also scored in Y2H interaction. This yields a sensitivity of
86% and a speciﬁcity of 58%. The veriﬁcation rate of our
screen (true positives plus true negatives/total interactions) is
66%, which compares well to global Y2H screens reported
earlier (Li et al, 2004; Rual et al, 2005). On the basis of these
data, we conclude that the detected E2 interactions for the hub
E3s are in agreement with functional E2–E3 pairs reported in
the literature, emphasizing the quality of interactions found in
our screen.
Validation of E2–E3 interactions by in vitro binding
Interestingly, we observed a high number of E3 interactions
with an uncharacterized E2 annotated as UBE2U. The UBE2U
protein (321 amino acids) is composed of a typical UBC-
domain,withaC-terminaltailattached.Nobiologicalfunction
has been described for this E2 yet, but microarray experiments
showed that UBE2U mRNA transcripts have been identiﬁed
mainly in tissues belonging to the urogenital tract. The UBE2U
gene is only present in mammalian genomes. We looked in
detail, which E3 enzymes were able to interact with this E2.
One of the interacting E3s was MDM2. MDM2 has been
identiﬁed as a major regulator of the cellular level and activity
of the transcriptional regulator p53 (Momand et al, 1992). The
signiﬁcance of MDM2 incontrollingnormalcellular behaviour
has become clear by the observation that in more than 50% of
human tumours alterations in the p53 has been observed and
in at least 7% of these cases, the MDM2 protein is affected
(Momand et al, 1998). MDM2 has been identiﬁed as an E3
ligase, capable of ubiquitinating both itself and p53, targeting
them for proteasomal degradation (Nakamura et al, 2000). For
this action, MDM2 has a C-terminal Cys3–His2–Cys3 RING-
ﬁnger, which was shown earlier to be able to interact with
UBE2D2(UbcH5B) (Saville et al, 2004). To investigate whether
other E2s identiﬁed in the two-hybrid screen can bind to
MDM2, we focussed on the MDM2–UBE2U interaction that
seemed quite strong from the Y2H. To investigate the MDM2–
UBE2U interaction in more detail, we performed GST-pull-
downassayswithimmobilizedWTandcatalyticmutant(C85A
or C89A) GST–E2 UBC domains. As a negative control,
GST–UBE2E1(UbcH6) was included. As shown in Figure 6A,
MDM2 is captured by UBE2U and as expected also by
UBE2D2(UbcH5B). Interestingly, UBE2U binds more efﬁ-
ciently to MDM2 than UBE2D2(UbcH5B). No binding could
be observed with GSTalone or GST–UBE2E1(UbcH6), reﬂect-
ing the speciﬁc nature of MDM2–E2 interactions. As expected,
mutation of the catalytic cysteine did not affect the interac-
tions. Next, the GST–E2 enzymes were applied to lysates of
human osteosarcoma cells (U2OS), which contain higher
levels of MDM2 because of ampliﬁcation or over-expression
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Figure 6 UBE2U physically interacts with MDM2. (A) HEK293T cells were
transiently transfected with myc-tagged MDM2, lysed and incubated with GST–
E2s immobilized on gluthathion-agarose beads. Bound material was resolved on
7.5% SDS–PAGE and proteins were visualized after immunoblotting with
antibodies against myc. (B) Untransfected U2OS cells were lysed and combined
with GST–E2s as in panel A. Immunoblotting was carried out using MDM2
antibodies (upper panel) and using p53 antibodies after reprobing (lower panel).
Arrow indicates MDM2 signal, asterisk indicates background band.
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8 Molecular Systems Biology 2009 & 2009 EMBO and Macmillan Publishers Limited(Florenes et al, 1994). Figure 6B shows an efﬁcient pull-down
of endogenous MDM2 with both GST–UBE2U and GST–
UBE2U C89A enzymes. Binding could also be observed
when GST–UBE2D2(UbcH5B) WT and C85A where used,
but no binding could be seen with GST alone or GST–
UBE2E1(UbcH6). The GST–E2 bound MDM2 fractions were
alsotestedbyantibodiesagainstp53.Figure6Bshowsthatp53
could be detected when MDM2 was captured on GST–E2
enzymes. These results indicate that UBE2U can bind to
MDM2, conﬁrming the Y2H results, and that the p53 substrate
is part of the captured complex.
To validate the Y2H interactions for other E2 proteins we
used the GST-pull-down approach for several E3 nodes
expressed in crude bacterial lysates as 6xhistidine-tagged
proteins. Sixty binary interactions were tested, which cover
the spectrum of different distributions between hub and non-
hub proteins. Figure 7 shows that 50 interactions were in
agreementwiththeY2Hanalysis:23interactionswerepositive
in both assays (true positives) and 27 scored negative in both
assays. Of the other 10 interactions 9 were only positive in the
GST-pull-down approach, whereas one interaction (PJA2-
UBE2H) only scored positive in the Y2H screen. Comparison
of the data sets indicates 96% speciﬁcity (TN/(FPþTN)¼27/
(1þ27)) and 72% sensitivity (TP/(TPþFN)¼23/(23þ9))
(Figure 5) and with a veriﬁcation rate of 83%, which is in
agreement with earlier reported veriﬁcation rates of global
Y2H screens (Li et al, 2004; Rual et al, 2005). Together, this
underscores the high quality of our E2–E3 interaction dataset.
Altering the E3-interaction speciﬁcity of the
K63-speciﬁc UBE2N(Ubc 13)
Elucidation of the 3D structures of several E2–E3 complexes
showed that the E3 interaction surface of E2s comprises the N-
terminal helix 1, loop 1 between b-strands 3 and 4 and loop 2
between helices 310 and 2 (Figure 8A) (Huang et al, 1999;
Zheng et al, 2000; Dominguez et al, 2004; Christensen et al,
2007; Xu et al, 2008). We noted that the E3 interaction patterns
of UBE2D2(UbcH5B) and of UBE2N(Ubc13) display a B60%
overlap (Figure 8D). This E2 pair is particularly interesting as
the primary sequences are rather divergent and UBE2D2
directs poly-ubiquitin conjugation through K48 linkages
(Brzovic et al, 2006), whereas UBE2N forms K63-linked
ubiquitin chains as a heterodimer with the catalytically
inactive E2s, UBE2V1 and UBE2V2(MMS2) (VanDemark
et al, 2001).
To obtain more insight into the E3 interaction speciﬁcity of
UBE2N we decided to mutate residues in helix 1, loop 1 or loop 2.
We reasoned that mutation of such residues into their UBE2D2
counterparts could allow interactions, which would otherwisebe
speciﬁc to UBE2D2. Comparing residues between UBE2D2 and
UBE2N pointed to P5 and I9 in helix 1, E60 of loop 1 and Q100 in
loop 2 as speciﬁcity candidates in UBE2N (Figure 8A). We
changed thesepositions intotheUBE2D2 residues andre-arrayed
our library of 251 B42–E3(RING) clones to analyse the E3
interaction proﬁles of the UBE2N mutants. First, we noted that
loop 1 and loop 2 of UBE2N are particularly sensitive to mutation
as the E60T and Q100T mutants fail to interact with any E3
despite normal expression levels (Figure 8B and D). Interestingly,
the E3 interaction pattern of P5L/I9H differs from both UBE2N
and UBE2D2 (Figure 8B and C). This mutant still shares 13/29
interactions with WT UBE2N and gains seven new E3 interac-
tions. Of these, ﬁve E3s (RMND5B, 1810074P20RIK, RNF150,
MAP3K1 and MUL1) are shared with UBE2D2 and two (RNF183
and CHFR) are unique to the P5L/I9H mutant (Figure 8C;
Supplementary Table III). MAP3K1 and MUL1 (or MULAN) are
particularly interesting as MAP3K1 has been identiﬁed as the E3
enzyme responsible for degradation of the ERK1/2 kinases
involved in signal transduction pathways (Lu et al, 2002) and
MUL1 has a role in mitochondrial dynamics (Li et al, 2008). The
P5L/I9H-speciﬁc interactor CHFR has been identiﬁed as the E3
ligase responsible for degradation of HDAC1, leading to
upregulation of the Cdk inhibitor p21 and the metastasis markers
KAI1 and E-cadherin (Oh et al, 2009). These observations
indicate that exogenous expression of P5L/I9H UBE2N may
result in switching from K48-linked to K63-linked polyubiquitin
chains conjugated to substrates of the above-mentioned E3
ligases. In this respect it is important to note that the UBE2N
surface responsible for heterodimerization with UBE2V1 and
UBE2V2 does not overlap with the E3 interaction surface that
comprises helix 1, loop 1 and loop 2 (VanDemark et al, 2001).
In conclusion, our mutational approach exploits the
high-quality E2–E3 interaction dataset to design E2 enzymes
with new E3 interaction speciﬁcities, which can be applied
to alter ubiquitination pathways to manipulate protein
function in cells.
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Figure 7 GST-pull-down analysis between (hub) E2 and E3 enzymes. To
validate yeast two-hybrid interactions, GST-pull-down analysis was performed
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asterisk indicates a speciﬁc signal.
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The selectivity of interactions between E2 enzymes and RING-
type E3 ligases represent a central and crucial part of the
ubiquitin-conjugation pathways in organisms. To explore the
genome-wide landscape of E2–E3 complexes, we performed a
comprehensive Y2H screen to study the selective behaviour of
thesebinaryinteractions.Speciﬁcinteractionsmediatedbythe
E2 UBC-fold and the E3 RING-ﬁnger domain were tested
between arrayed collections of 35 UBC-folds and 250 RING-
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loadedE2sontheirRINGdomainononeendandsubstrateson
the other acting like a scaffold (Ardley and Robinson, 2005).
The few structures known for E2–E3 complexes indicate that
themajordeterminants ofE2–E3 bindingandselectivity reside
within these domains. Our screen focussed on the molecular
determinants of E2–E3 selectivity as the primary characteristic
of speciﬁcity that does not take the secondary parameterssuch
as spatial and temporal interactions into account.
Interactions between human E2 and E3 enzymes
Our database searches retrieved 35 human E2 enzymes that
contain the highly conserved UBC-fold. Besides well-known
E2 enzymes such as UBE2C(UbcH10) (Summers et al, 2008),
members of the UbcH5 subfamily (Seufert and Jentsch, 1990)
and UBE2N(Ubc13) (Deng et al, 2000) all having clear roles in
ubiquitination; more divergent E2 enzymes have been
identiﬁed. Among these E2s are UBE2F, UBE2W, BIRC6
(Apollon), UBE2O(E2-230K) and UBE2V1 and UBE2V2. All
functional E2s contain the UBC-fold, providing them with a
molecular platform for RING-domain interaction and render-
ing them as catalysts in the process of ubiquitin (-like)
conjugation (Burroughs et al, 2008). We also included the
UBE2D2K63EmutantintheE2arrays,evaluatingtheeffectsof
this E2–E3 interaction mutant. The selection of RING-type E3
domains included in our screen covers the majority of the
human E3 enzymes.
Our results showed that multiple E2s are able to interact
withmorethanoneE3andviceversa.E2enzymesthatinteract
with many E3s were UBE2U, members of the UbcH5 family
and UBE2N. UBE2U showed the highest levels of E3 interac-
tions. The restricted expression pattern of UBE2U could
explain why it has not been identiﬁed earlier as an
E3(RING)-interactor. E2s such as UBE2V1 and UBE2V2 did
not show E3 interactions. Although they contain a UBC-fold
that could potentially interact with E3s, they lack the catalytic
cysteine residue required for ubiquitin acceptance (Deng et al,
2000). Some E2s are involved in the conjugation of ubiquitin-
like proteins, such as UBE2M(UbcH12) and UBE2F(NCE2) for
NEDD8 andUBEI(Ubc9) for SUMO(DyeandSchulman, 2007);
(Kerscher et al, 2006; Huang et al, 2009). In addition,
UBE2O(E2-230K) and BIRC6(apollon) did not interact with
E3s. Both BIRC6 and UBE2O are thought to contain a chimeric
E2/E3 domain, which would obviate the need for an
exogenous E3 ligase (Berleth and Pickart, 1996). Other E2s
failed to interact with E3s in our screen, like the human
homologs of the yeast Rad6p, UBE2A(hHr6A) and
UBE2B(hHr6B). A possible explanation is that the Rad6p is
phosphorylated at serine 120 by CDK-1 and -2 (Sarcevic et al,
2002) and this modiﬁcation increases the E2 activity. Residue
Ser120 is conserved in Rad6p homologs, but it is unclear
whetherthemodiﬁcationincreasesthebindingbetweentheE2
and the E3 or whether it inﬂuences the activity. Another E2,
UBE2C(UbcH10), is required for degradation of mitotic cyclins
and cell-cycle progression. Recently, the N-terminal extension
of UBE2C, which is missing in our construct, has been
implicated in regulating substrate ubiquitination and the
number of lysines ubiquitinated in these substrates through
interaction with the APC E3 ligase (Summers et al, 2008).
Some E3 enzymes were more connected than others.
Strikingly, CADPS2 showed the highest number of interac-
tions, but it has not been annotated as an E3 enzyme yet. This
observation could indicate the identiﬁcation of a new or
deviant domain that could interact with E2 enzymes and
potentially be involved in ubiquitination. Within the E3s with
the highest number of E2 interactions, members of two closely
related proteins families were found. The RNF130, RNF167
and RNF150 proteins belong to the Goliath family and are
involved in apoptosis and embryonic development (Bouchard
and Cote, 1993; Anandasabapathy et al, 2003; Guais et al,
2006). These E3s showed a pattern of overlapping E2
interactions. In addition, ZNRF1, ZNRF2 and ZNRF4 were
found among the highest interactors. The ZNRF proteins
shared many interactions with the same E2s. These two
protein families indicate that conserved E3s are clustered
together to interact with the same panel of many E2s.
Heterodimeric complexes, such as BRCA1–BARD1, MDM2–
MDMX and BMI1–Ring1B, represent a special group of E3
enzymes. In those cases, one RING provides the complex with
E3 activity, but only in association with the partnering RING.
The active RING serves as a binding subunit for E2 enzymes,
but the function of the other RING is often unclear. This
situation is not represented in our two-hybrid set-up. In a
recent Y2H study, the BRCA1–BARD1 RING domains were
fused and tested for E2 interactions (Christensen et al, 2007).
Inthisset-up,theE2proteinsUBE2D1,-D2,-D3,-E1,-E2,-E3,-
I, -K, -L3, -N and W scored positive. In contrast, we only
observe interactions with UBE2J2, -U and -W for the isolated
BRCA1 RING domain in the LacZ read-out. This clearly
indicates that screening with fused RING dimers yields
different results from screening with isolated RING domains.
It remains, however, unclear what the underlying molecular
determinants of these differences are and a potential role for
the inactive dimerization partners needs to be established.
We have shown earlier that the CNOT4 D48K E49K mutant
has lost its interactions with UBE2D1-4(UbcH5A-D),
UBE2E1(UbcH6) and UBE2E3(UbcH9) (Winkler et al, 2004).
WeshowherethattheRING-ﬁngerofCNOT4 isabletointeract
with UBE2W and that the mutant also loses this interaction.
T h e s eo b s e r v a t i o n si n d i c a t et h a tt h er e s i d u e sw i t h i nU B E 2 D 1 - 4 ,
UBE2E1, UBE2E3 and UBE2W required for RING interactions
are coupled with respect to their involvement in determining
RING speciﬁcity. The CNOT4 double mutant, however, gained
a stronger signal with UBE2N(Ubc13) when compared with
WT CNOT4. From this point of view, the RING-interacting
residues in UBE2N are likely to mediate binding in an opposite
manner, gaining a stronger RING association. Unexpectedly,
residues at position 63 are not highly conserved between the
CNOT4-interacting E2 domains, indicating a more complex
recognition mode. The mutant RING-ﬁnger displays a speciﬁc
interaction with the UBE2D2 K63E mutant, but not with the
WT UBE2D2, altering the speciﬁcity of interaction. When
testing the UBE2D2 K63E mutant, it gained an interaction with
NFX1. In addition, the change in E3 interaction pattern of
UBE2D2 indicates that, although the E2–E3 interface is
conserved, individual residues in this interface have different
contributions in achieving interaction speciﬁcity among
different pairs of E2s and E3s. Molecular modelling and
docking approaches of E2–E3 pairs may provide more insight
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regarded that the UBC-fold of the E2 and the RING-ﬁnger
domain of the E3s represent the interaction surfaces for
E2–E3(RING) interactions (Joazeiro et al, 1999; Dye and
Schulman, 2007). However, in some cases residues outside
these domains contribute as exempliﬁed by the UBE2-
L3(UbcH7)-c-Cbl structure. The RING domain of c-Cbl packs
onto the tyrosine kinase-binding (TKB) domain and a
connecting linker harbours several E2-interacting residues
(Zheng et al, 2000). The absence of the TKB domain and linker
can explain why no c-Cbl interactions were recovered in our
interaction screen. Another example is the Hsp70-interacting
protein (CHIP), which exclusively interacts with the UBC-fold
of UBE2D1(UbcH5A) through its RING-type U-box domain
(Xu et al, 2008). No CHIP interactions were recovered in
our screen. The false negatives of our screen as exempliﬁed by
c-Cbl and CHIP can be related to the absence of interaction
residues outside the E3(RING) domain, misfolding and/or
mislocalization of the E3s in our screen. Nevertheless, we
describe 295 novel E2–E3 interactions and we identify 66
E3(RING) proteins as novel E2 interactors. Together, this
represents an important step forward in our knowledge of the
E2 and E3 proteins of the human ubiquitin system.
In a ﬁrst attempt to understand E3 speciﬁcities in directing
different types of ubiquitin linkages we focussed on the
UBE2D2(UbcH5b)–UBE2N(Ubc13) E2 pair. Substitution of
residues in the E3 interaction surfaces of the K63-speciﬁc
UBE2N yielded the P5L/I9H mutant (Figure 8). This mutant in
the N-terminal helix of UBE2N gained ﬁve E3 interactions
shared with UBE2D2 (speciﬁc for K48 linkages directing
proteosomal degradation) and two unique interactions.
UBE2N is catalytically active as a heterodimeric E2 with
UBE2V1(Mms2) or UBE2V2. Importantly, the crystal structure
of yeast Ubc13/MMS2 indicates that the P5L/I9H mutations
will not interfere with heterodimer formation of UBE2N
(VanDemark et al, 2001). Thus, the P5L/I9H mutant of UBE2N
may redirect K63- to K48-linked poly-ubiquitin chains on a
selected set of UBE2D2 substrates on expression in cells. We
expect that the UBE2N–UBE2D2 pair represents only the ﬁrst
example and that the E2–E3 interaction data harbour many
more possibilities for re-designing ubiquitin pathways.
Topology of the E2–E3 network
It is clear that E2–E3 interactions are not following a normal
distribution. Both E2s and E3s showed a small number of
highly connected proteins, followed by a larger group of
enzymes with lesser interactions and so on. The identiﬁed
highly interacting E2 and E3 proteins share many structural
features within their complete UBC-fold and the E3-interacting
interfaceresidues.Thesehighlevelsofsequenceidentityallow
these hubs to interact with certain clusters of RINGs. For some
of these hubs, their biological function is expected to involve
redundancy. Evolutionary duplication of, for example, mem-
bers of the UBE2D(UbcH5)-subgroup allows these E2s to
interact with the same set of RING-ﬁngers and, possibly, to
ubiquitinate the same substrates. E2 enzymes that are more
divergent in their interface sequence, such as UBE2N, have a
different E3 interaction proﬁle and are interacting with a
different subcluster of RING E3s.
Proteins with many connections are holding large sub-
networks together, forming complete, interconnected net-
works (Jeong et al, 2001). Deletion of these nodes has been
shown to be associated with network robustness, pointing out
that many hub proteins are essential for remaining the
integrity of the network and the complete system (Jeong
et al, 2001). In the E2–E3 network, UBE2U, members of
the UBE2D1-4(UbcH5A-B) family, UBE2E1(UbcH6) and
UBE2E3(UbcH9),UBE2NandUBE2G2behaveashubproteins.
Inactivation of these E2 proteins could potentially have
dramatic contributions to large regions of the E2–E3 network
and to cellular ubiquitination. As only a few substrates have
been identiﬁed yet, we evaluated the in silico effect of deletion
of hub E2s, by counting the numbers of E2s that become
unconnected. Deletion of UBE2U, UBE2G2 or UBE2N has
dramatic effects on the number of unconnected E3s, indicating
that these hubs are indeed holding the E2–E3 network
together. Strikingly, two of these three hubs have speciﬁc
biologicalroles,UBE2N is involvedin K63-chain synthesis and
UBE2G2 is an ER-resident E2 involved in ERAD. In contrast,
deletionofanyoftheUBE2Ds orUBE2E1 haslittleeffectonthe
network; all E3s that remain connected are already bound to a
closely related E2 enzyme. The observation that members of
the UBE2D1–4 family, are biologically implicated in the
degradation of abnormally folded and short-lived proteins,
could be related to the expansion of the UBE2D family. Indeed,
both the UBE2D1–4 orthologs UBC4 and UBC5 in Sacchar-
omyces cerevisiae are functionally redundant and deletion
impairsgrowth,temperaturetolerance,proteinmisfoldingand
stress responses (Seufert and Jentsch, 1990). Interestingly,
deletion of E2s known to conjugate UBLs, like UBE2I (for
SUMO) and UBE2M or UBE2F (for NEDD8), does not give rise
to any unconnected E3, indicating that these E2s are less
important for maintaining the integrity of the ubiquitin
network.
Physical E2–E3 interactions form the basis of ubiquitination
activity and are required for an E2–E3 pair to become
functional. By comparing the Y2H data with E2–E3 pairs that
arereported tobefunctionalinubiquitination,weshowedthat
the physical interactions among hub proteins for the majority
of E2–E3 pairs correlate very well with reported biochemically
active E2–E3 pairs. In addition, comparing all detected Y2H
interactions or those that are having only one or more
interactions was in good agreement with literature-curated
E2–E3 pairs. These comparisons indicate that the ability of an
E2–E3pairtobefunctional inubiquitination reactionsisbased
on determinants of physical interaction. In addition, physical
interactions could be used to predict the functionality of an
E2–E3 interaction. The independent validation of a subset of
E2–E3 in GST-pull-down-binding experiments provides a good
coverage of the found Y2H interactions and, combined with
the above-mentioned, indicates a high quality of the E2–E3
interactions determined by Y2H.
The E2–E3 network can be ﬁtted into the overall organiza-
tion of the ubiquitination process. The two known ubiquitin
E1s are activating ubiquitin and interact with the E2s
to transfer ubiquitin in a strictly hierarchical organization
(Haas et al, 1982; Jin et al, 2007). Then the E2–E3 inter-
actions take place in their speciﬁc manner and ﬁnally the
ubiquitin is transferred to the E3-bound substrate (Dye and
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E3-substrate speciﬁcity is available, some well-characterized
E3s have been shown to mediate ubiquitination of multiple
substrates (Tanaka et al, 2004; Boulton, 2006; Lin and
Mak, 2007). This stresses the need for genome-wide
analysis of interactions between E3 enzymes and their
substrates. However, this may be hampered by the fact that
for many E3s and substrates the binding sites are poorly
characterized, a small amount of conservation among these
sites is observed and the potential need for the post-
translational modiﬁcations before E3 recognition of the
substrate. Besides this, the E1–E2–E3-substrate ubiquitination
super networkcan be regardedas a system that combines both
hierarchical and the highly interconnected properties of E2–E3
interactions.
Taken all together, we report a high-quality framework
centredonthefunctionaldomainsofE2andE3enzymesinthe
human ubiquitination system. Exhaustive screening of E2–E3
interactions provides insight into the arrangement of proteins
in this complex biological system. These binary interactions
can be used to initiate follow-up studies concerning the
structural aspects of E2–E3 pairs, such as modelling and
docking of E2–E3 interactions to gain more insight into the
underlying speciﬁcity. Although not all of these interactions
will occur physiologically, for example because there are
barriers in space and time preventing the coming together of
E2s and E3s, these results provide a highly detailed, global
network of E2–E3 interactions and their role in ubiquitination
as a whole system. The interactions obtained with the mutant
E2 could initiate new lines of synthetic ubiquitin research
aimed at designed modulation of the system. Together, these
experimental interactions provide a rich source of information
and can be used to guide future research in ubiquitination and
E2–E3 selectivity.
Materials and methods
Plasmid procedures
Full length or EST cDNAs of human ubiquitin-conjugating enzymes
andhumanRING-typeE3 ubiquitinprotein ligaseswereobtainedfrom
the Deutsches Ressourcenzentrum fur Genomforschung GmbH
(RZPD, Berlin, Germany). PCR primers (Biolegio, Nijmegen, the
Netherlands) were used to amplify the E2 UBC-fold and the E3 RING-
ﬁnger catalytic domains (including 10 N-terminal and 10 C-terminal
residues) and these domains were sub-cloned either in pEG202-NLS
or in the pJG4-5 plasmid to generate E2 or RING constructs fused
to the C-terminus of the Escherichia coli LexA (DNA-binding
domain) and B42 (AD) proteins, respectively. cDNAs encoding E2
enzymes were sub-cloned in pGEX-4T-1 to generate GST fusions.
Mutagenesis was performed using QuickChange II Site-Directed
mutagenesis (Stratagene), according to the manufacturer’s instruc-
tions. The mammalian expression plasmid myc-Mdm2 has been
described earlier (van der Horst et al, 2006). All constructs were
completely veriﬁed by DNA sequencing. Additional information
concerning cDNAs, ampliﬁcation primers and cloning procedures is
available on request.
Antibodies
Monoclonal antibodies recognizing LexA(2–12), GST(B14),
MDM2(SMP-14) and p53(DO1) were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA) and an HRP-coupled anti-penta-
his antibody was purchased from Qiagen (Qiagen, Venlo, the
Netherlands). Monoclonal antibodies against HA(12CA5) and
CNOT4(19A20) were puriﬁed from hybridomas as reported elsewhere
(Winkler et al, 2004).
Yeast manipulation and array generation
Growth and manipulation of the parental yeast strain EGY48 (MAT a,
his3, trp1, ura3, 6LexAop–LEU2) was carried out as described before
(Winkler et al, 2004). Mating type changing was carried out by using
HO-endonuclease as described earlier (Burke et al, 2000). To generate
a standardized array of yeast cells expressing all LexA–E2 fusions,
three individual veriﬁed DB–E2 bacterial shufﬂe plasmids were co-
transformed together with the LacZ reporter plasmid (LexAop)8
pSH18-34 in EGY48a, whereas AD-RING fusions were transformed
in EGY48a by using a LiOAc/DMSO transformation in 96-well plates
(Gietz and Woods, 2002). Transformants were selected on solid
synthetic complete (SC) medium without histidine (H) and uracil (U)
in the case of EGY48a (LexA–UBC/pSH18-34) or without tryptophan
(W) for EGY48a (B42–RING) by incubation at 301C for 2–3 days.
Correct transformation with the appropriate fusion protein was
veriﬁed using colony PCR as described before (Burke et al, 2000). In
the E2 array, transformants of the EGY48a strains were arranged in a
square of four spots, LexA–E2s were spotted in three independent
biological transformants, combined with a transformant expressing
LexA alone.
Semi-high-throughput yeast two-hybrid analysis
Individual EGY48a transformants bearing B42–RING fusions were
inoculated in liquid SC W
  medium, grown overnight at 301C shaken
at 230r.p.m. Liquid cultures were transferred on solid SC W
  by
manual pinning in 384 format using manual pinning tools (VP384F),
library copiers (VP381) and colony copiers (VP380) from V & P
Scientiﬁc, Inc. (San Diego, CA, USA) and grown overnight to increase
the amount of cells used for mating. In parallel, LexA–E2-transformed
EGY48a cells were pinned on solid SC HU
 . Mating was performed by
pinning the LexA–E2 and the B42–RING transformants at exactly the
same position on solid, non-selective YPD medium for 24h at 301C.
Diploids were selected at 301C for 48h on SC HWU
  plates. To
visualize putative E2–E3 interactions, pre-selected diploids were
transferred to read-out plates. For colorimetric selection, diploids
were pinned on SC HWU
  plates supplemented with X-Gal, and for
auxotrophic selection, diploids were transferred to SC HWUL
  plates.
Both types of read-out were assessed under both inducing conditions,
with galactose as the sole carbon source as well as under repressing
conditions(withglucoseascarbonsource).Plateswereincubatedfora
period of 24–96h and pictures of the yeast colonies were taken at ﬁxed
intervals.
Spot quantiﬁcation analysis
Digital images of yeast plates to quantify yeast spot size and blue
staining intensity were carried out systematically at ﬁxed intervals by
using a standardized digital camera set-up. Spot size and blue staining
intensity were quantiﬁed using a earlier reported Java-based spot-size
measuring software algorithm (Collins et al, 2006), according to the
developer’s instructions and usingan in-housewritten grid-based blue
intensity measure algorithm, respectively.
Western blot veriﬁcation of protein expression
To conﬁrm correct protein expression, total protein lysates were
prepared (Kushnirov, 2000). Brieﬂy, individual, freshly pinned yeast
colonies were grown in appropriate medium, overnight in 96-well
plates at 301C under continuous shaking. Cells were centrifuged,
re-suspended in 0.1M NaOH and incubated for 5min at room
temperature. Next, cells were centrifuged and resuspended in 1 
sample buffer, boiled for 5min and centrifuged. Standard, proteins
wereseparatedona17.5%SDS–PAGEgel,transferredtonitrocellulose
membranes and probed with mouse anti-HA or anti-LexA antibodies
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instructions (Pierce).
Recombinant proteins
Full length or regions encoding the UBC-fold of individual E2s were
subcloned in pGEX-4T-1andexpressedasGST–E2fusionproteinsinE.
coli BL21(DE3) as described earlier (Winkler et al, 2004). Brieﬂy,
freshly transformed colonies were grown to mid-log phase in LB-
medium, induced with 0.4mM isopropyl-D-thiogalactopyranoside
(IPTG) for 3h at 301C, and lysed in 25ml ice-cold lysis buffer
(300mM KCl, 50mM Tris–HCl pH 8.0, 2mM EDTA 0.1% Triton X-100,
20% sucrose) containing 1mM dithiothreitol (DTT), 0.5mM phenyl-
methylsulfonyl ﬂuoride (PMSF), protease inhibitor cocktail (Roche)
and 25mg/mllysozyme. After freeze thawing and soniﬁcation, lysates
were centrifuged at 50000r.p.m. for 1h at 41C. Crude lysates were
stored at  801C. Constructs expressing recombinant human his–
thioredoxin–RING fusions in the pLICHIS vector backbone were
expressedin E.coliBL21(DE3)andproteinexpressionexceptthatIPTG
induction was overnight at 241C in LB-medium supplemented with
100 mM ZnCl2.
Mammalian cell culture
Human embryonic kidney cells (HEK293T) and human osteosarcoma
cells (U2OS) were maintained in DMEM supplemented with gluta-
mine, penicillin/streptomycin and 10% FBS under 5% CO2 at 371C.
293Tcells were grown to 60–70% conﬂuency and transfections were
carried out using FuGENE6 according to the suppliers’ instructions
with myc-tagged MDM2; 24h after transfection, cells were washed
twice with ice-cold PBS, lysed in RIPA (50mM Tris–HCl pH 8.0,
150mM NaCl, 1.0% NP-40, 0.5% sodium deoxycholate, 0.1% SDS,
1mM DTT, 0.5mM PMSF and 1mg/ml aprotonin, leupeptin and
pepstatin), cleared by centrifugation at 14kr.p.m. at 41C. U2OS cells
were treated with or without 20mM MG132 for 4h before lysis in
RIPA-buffer.
GST-pull-down assays
GST–E2 proteins were immobilized on gluthathione-agarose beads
(Sigma) and incubated with 5mg of His6-CNOT4-N78/His6-CNOT4-
N227 or U2OS or 293T lysates for 2h at 41C in G/A-buffer (50mM
potassium phosphate pH 6.6, 50mM KCl, 0.1% NP-40, 10mM ZnCl2,
0.5mM PMSF, 1mM DTT, 1mg/ml aprotonin, leupeptin and pepstatin
(All Sigma)). GST–E2–RING pull-down analysis was performed by
incubation of GST–E2 proteins on beads with his–RING bacterial
lysate (approximately 5mg of RING-fusion protein) for 3h at 41C.
Beads were washed three times with G/A-buffer, bound proteins
resolved by SDS–PAGE and visualized with immunoblotting.
Data set
The protein interactions from this publication have been submitted to
theIMEx(http://imex.sf.net)consortiumthroughIntAct(Kerrienetal,
2007) and assigned the identiﬁer IM-9597.
Note added in proof
Although the revised version of this manuscript was under review,
Markson et al published a global screen of human E2–E3 interactions
using full-length cDNAs in the Gal4-based Y2H system (Markson et al,
Genome Res. 2009, doi:10.1101/gr.093963.109).
Supplementary information
Supplementary information is available at the Molecular Systems
Biology website (www.nature.com/msb).
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